Continue to Site »
Site will load in 15 seconds
Advertisment: Fluence » Fluence Order 95 » CBT ROS Banner 970x250 Sept 26 - October 2025 » FLU-DBA_PYTHN_970-x-250

Federal Trade Commission Puts Companies on Notice: CBD is Not the ‘Wild West’

The Federal Trade Commission (FTC) is sending a message to cannabidiol (CBD) companies that it will not tolerate deceptive marketing practices.


The FTC took its first-ever enforcement actions against CBD companies this past December, obtaining settlements against six companies for deceptive marketing. The enforcement was part of Operation CBDeceit, targeting companies that made unproven claims about their products’ ability to treat diseases and medical conditions, such as cancer, diabetes, and Alzheimer’s disease.

In doing so, the agency intended to send a message: a new market is subject to the same laws and enforcement action as an established one.

“The six settlements announced today send a clear message to the burgeoning CBD industry: Don’t make spurious health claims that are unsupported by medical science,” Andrew Smith, director of the FTC’s Bureau of Consumer Protection, said in a Dec. 17 release announcing the action. “Otherwise, don’t be surprised if you hear from the FTC.”

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg

Leslie Fair, a senior attorney at the bureau, took it a step further in an agency blog published that day.

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg

“‘It’s the Wild West out there!’ How often have you heard that statement made about health claims for products containing CBD? But here’s the thing: It’s not the Wild West,” she wrote. “In fact, health-related representations for CBD products are subject to the same established requirements of scientific substantiation the FTC has applied for decades to any advertised health claim.”

The six companies—Bionatrol Health, LLC, CBD Meds, Inc., Epichouse LLC, HempmeCBD, Reef Industries Inc., and Steves Distributing, LLC—made health claims without necessary scientific evidence. Each company settled with the government and was required to end all misleading advertising and notify consumers of the agreement. Also, five of those companies were assessed fines ranging from $20,000 to $85,000.

Advertisment: Emerald Harvest » Emerald Harvest Order 115 » CBT ROS Leaderboard Ad 728x90 October 2025 » eh-360-web-banner-728x90

According to the agency release, these companies are also prohibited from making any claims of prevention, treatment, or safety in the future unless they have human clinical testing to back this up. The companies are also required to have “competent and reliable scientific evidence” to support any other types of health claims.

Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg
Advertisment: Frank Mayer » Frank Mayer Order 84 » CBT ROS Medium Rectangle 300x250 October 2025 » Frank Mayer CBT Web Ad - July 2025.jpg
Page 1 of 131
Next Page
Advertisment: Fluence » Fluence Order 95 » CBT ROS Mobile Adhesion 360x120 October 2025 » FLU-DBA_PYTHN_360-x-120